The proviral genome of the 32H reisolate of simian immunodeficiency of macaques (SIVmac32H) has been cloned and sequenced. Including both long terminal repeats, it is 10277 base pairs in length and contains open reading frames for all known SIV genes (gag, pol, vif, vpx, ~pr, tat, rev, env and neJ). This is the first report of an infectious SIVmac molecular clone which contains no premature termination codons. Three molecular clones of SIVmac32H have been constructed differing in sequence only within their last 1.2 kb. Two of the molecular clones, SIVmac32H(pJS) and SIVmae32H (pC8), differ in the nef coding region by an in-frame deletion of four amino acids in pC8 and two conservative amino acid changes; other nucleotide changes in the 3' LTR were not associated with known functionally critical motifs. The third clone, SIVmac32H(pB1), contains the last 1.2 kb of the SIVmae251 clone pBK28. The biological properties of virus produced after electroporation of these clones into C8166 cells has been assessed by infection of rhesus and cynomolgus macaques, time to seroconversion and by induction of cytopathic effects upon co-cultivation of infected rhesus peripheral blood lymphocytes with C8166 cells. The viruses obtained from these clones have identical growth kinetics in vitro but differ in their ability to persist in macaques. Macaques infected with p J5 derived virus remain viraemic longer than macaques infected with pC8-derived virus. PCR analysis of circulating provirus indicates that the nefgene evolved over time in p J5 virusinfected macaques, whereas late in infection in pC8 virus-infected macaques the nefgene remained invariant in sequence. These results support the observation that a nefdeletion mutant of SIVmac239 lost its pathogenic potential and resulted in low-level viraemia when rhesus macaques were infected. Virus challenge pools for vaccine studies have been prepared for p J5 using both human and monkey cell substrates and these stocks have been titrated both in vitro and in vivo. Virus has also been prepared from pC8 and titrated in vitro. This virus pool is being assessed as an attenuated live-virus vaccine in macaques. Since only virus originating from the SIVmac239 molecular clone is known to cause AIDSlike symptoms in rhesus macaques consistently, the SIVmac32H molecular clones should tell us more about which viral sequence features are important for the pathogenesis of AIDS.
The proviral genome of the 32H reisolate of simian immunodeficiency of macaques (SIVmac32H) has been cloned and sequenced. Including both long terminal repeats, it is 10277 base pairs in length and contains open reading frames for all known SIV genes (gag, pol, vif, vpx, ~pr, tat, rev, env and neJ) . This is the first report of an infectious SIVmac molecular clone which contains no premature termination codons. Three molecular clones of SIVmac32H have been constructed differing in sequence only within their last 1.2 kb. Two of the molecular clones, SIVmac32H(pJS) and SIVmae32H (pC8), differ in the nef coding region by an in-frame deletion of four amino acids in pC8 and two conservative amino acid changes; other nucleotide changes in the 3' LTR were not associated with known functionally critical motifs. The third clone, SIVmac32H(pB1), contains the last 1.2 kb of the SIVmae251 clone pBK28. The biological properties of virus produced after electroporation of these clones into C8166 cells has been assessed by infection of rhesus and cynomolgus macaques, time to seroconversion and by induction of cytopathic effects upon co-cultivation of infected rhesus peripheral blood lymphocytes with C8166 cells. The viruses obtained from these clones have identical growth kinetics in vitro but differ in their ability to persist in macaques. Macaques infected with p J5 derived virus remain viraemic longer than macaques infected with pC8-derived virus. PCR analysis of circulating provirus indicates that the nefgene evolved over time in p J5 virusinfected macaques, whereas late in infection in pC8 virus-infected macaques the nefgene remained invariant in sequence. These results support the observation that a nefdeletion mutant of SIVmac239 lost its pathogenic potential and resulted in low-level viraemia when rhesus macaques were infected. Virus challenge pools for vaccine studies have been prepared for p J5 using both human and monkey cell substrates and these stocks have been titrated both in vitro and in vivo. Virus has also been prepared from pC8 and titrated in vitro. This virus pool is being assessed as an attenuated live-virus vaccine in macaques. Since only virus originating from the SIVmac239 molecular clone is known to cause AIDSlike symptoms in rhesus macaques consistently, the SIVmac32H molecular clones should tell us more about which viral sequence features are important for the pathogenesis of AIDS.
Introduction
The possibility of reversion or recombination when using live attenuated vaccines and the problems of incomplete inactivation of killed vaccines make a subunit approach -~ Present address: Department of Health Canada, Laboratory Center for Disease Control, Bureau for HIV/AIDS, Ottawa, Ontario, Canada K1A 0L2.
The nucleotide sequence data reported in this paper appear in the DDBJ, EMBL and GenBank Sequence Databases under accession number D01065. The nucleotide sequence of SIVmac32H(pJ5) and alignment with other SIVmac sequences has been presented in the October 1991 update of the Los Alamos Human Retroviruses and AIDS Database.
to AIDS vaccine development highly desirable. However, since human immunodeficiency virus (HIV) is highly variable and there is evidence that this antigenic variation may be driven by immune responses, studies using cloned virus and subunit vaccines from the same clone are essential in order to determine whether a subunit vaccine approach will successfully prevent infection with a completely homologous virus challenge. As simian immunodeficiency virus (SIV) is the closest relative of HIV-1 and HIV-2 (Hirsch et al., 1987; Franchini et al., 1987; Chakrabarti et al., 1987; Guyader et al., 1987) , the rhesus macaque animal model has been used in many of the vaccine trials to date (Carlson et at., 1990; Desrosiers et at., I989; Johnson et aL, 1992; Marthas et al., 1990; Murphey-Corb et al., t989; Stott et al., 1990; Cranage et al., 1992) . Assessment of the protection induced in these studies was complicated because both the inactivated whole virus vaccines and challenge virus were produced on human cells and that even formalin-fixed uninfected human cells can protect a proportion of vaccines under these conditions . The anti-human cell antibodies from the protected monkeys seem to correlate with protection (Langlois et al., 1992) . In a recent study, Hu & Benveniste (1992) have shown that a subunit vaccine prepared from the gpl60 of SIVmne can stimulate a protective response in macaques challenged with a homologous biological clone of SIVmne. However, in general these results have not yet been repeated by other groups using the SIVmac model.
In this study full-length molecular clones have been isolated from a virus pool known as the 32H reisolate of SIVmac, originating from a rhesus macaque infected with the same pool of SIVmac from which three other molecular clones, SIVmac251(pBK28), SIVmaclAll and SIVmac239 have previously been isolated (Daniel et al., 1985; Naidu et aI., 1988 ; Unger et al., 1992) . The 32H molecular clones are being used to examine the ability of subunit and attenuated versions of the clones to stimulate protective responses in vaccinated macaques. Recently, Kestler et al. (1991) showed that in vitro mutagenized virus containing an artificial large deletion in the nefgene was able to infect monkeys but that the infected animals maintained a very low virus load. Interestingly, two of the SIVmac32H molecular clones differ by a naturally occurring in-frame deletion of four amino acids from the nef protein. In view of this, the 32H molecular clones represent unique reagents for the study of the molecular parameters of SIV-mediated pathogenesis and may further delineate the important features enabling SIV to cause AIDS in macaques which in turn may suggest approaches that may be used to prevent AIDS. This paper describes the cloning, sequence and phenotypic comparisons, in vitro and in vivo growth properties and titration of vaccine challenge stocks of the SIVmac32H molecularly cloned virus.
Methods
Virus. The origin of the uncloned SIVmac32H (11/88 pool) has been reported previously . Briefly, a low passage SIVmac251 pool of virus (provided by Dr R. Desrosiers) was inoculated into a rhesus macaque, 32H. At 57 days post-inoculation peripheral blood mononuclear cells (PBMCs) were collected, cultured for 3 days with phytohaemagglutinin (PHA) and co-cultivated with PHA-stimulated human cord blood lymphocytes (CBLs) in the presence of interleukin-2 (IL-2). The culture was supplemented with freshly stimulated CBLs four times over 17 days and the adherent cell population was then co-cultivated with C8166 cells (human T cell line). The culture was further passaged every 3 or 4 days by the addition of three volumes of freshly grown C8166 cells. Cell-free supernatant was taken from a 250 ml culture at the fourth passage, filtered through a 022 ~m filter and frozen in 0.5 ml aliquots (11/88 pool), Cells from this passage were used as a source of SIV proviral DNA for PCR amplification to provide the missing 3' sequence for the generation of the C8 molecular clone (see below). The 11/88 virus pool was passaged an additional eight times on JM cells (human T cell line) over a total of 30 days and the cells were harvested at day 30 for DNA extraction and proviral cloning (JM cellular DNA).
Cells and cell lines. Macaque PBMCs were obtained from blood samples collected in preservative-free heparin by banding on Ficoll gradients. The PBMCs were stimulated with 1 gg/ml PHA for 72 h, then co-cultivated with stimulated CBLs or C8166 cells. Continuously growing human CD4 ÷ cell lines C8166 (European Collection of Animal Cell Cultures: Public Health Laboratory Service, U.K.) and JM were grown in RPMI 1640 medium supplemented with 10 % fetal calf serum (FCS).
Lambda cloning of SIDnac32H provirus. SIVmac32H-infected JM cellular DNA was prepared as described by Little (1987) and used to clone full-length SIV proviral genomes. To facilitate cloning full-length genomes, cellular DNA was digested with EcoRI, since it is known that this enzyme does not cut either SIVmac251 or SIVmac239 (Naidu et al., 1988) . A bacteriophage lambda library was constructed by ligating 9 to 25 kb fragments from sucrose gradient-fractionated EcoRI digests into the cloning vector Lambda Dash (Stratagene). The library was screened using a nick-translated 7-3kb BamHI fragment derived from SIVmac251(pBK28) (Naidu et al., 1988) . Two SIVmac-specific clones (13-3 and 17-3) were isolated from the 6-5 x 105 plaques screened, without library amplification. The insert DNA, approximately 17 kb in length, was subcloned into the EcoRI site of the plasmid vector pBluescript SK -(Stratagene) to obtain two plasmid clones, p13-3 and p17-3. Sequencing showed that both proviral clones terminated at a novel internal EcoRI site corresponding to a site (nucleotide 9017) between the tat and rev stop codons from the SIVmac251 molecular clone pBK28 (Naidu et al., 1988) . The sequence dissimilarity of the other end of the proviral clones (non-viral cellular DNA sequence) indicated that the two clones represented unique proviruses integrated into separate sites in the JM cellular DNA. Further analysis confirmed that the two clones (13-3 and 17-3) contained unique sequences corresponding to nucleotides 1 to 9017 from SIVmac251(pBK28).
Construction offidl-length provirus clones. In order to complete the provirus the missing segment of DNA between the novel EcoRI site and the 3' end of the 3' long terminal repeat (LTR) was amplified by PCR. Two oligonucleotides were used: EcoRI-LTR(+), 5'CAGA GAATTCGAGAAGTCCTCAGGA 3 ~ (the underlined nucleotides correspond to the proviral EcoRI site) and LTR-EcoRI(-), 5' CCAGGATCCTGCTAGGGATTTTCCTGCT 3' (the underlined nucleotides correspond to an added BamHI site). Total cell DNA from SIVmac32H-infected C8166 cells or JM cells, or plasmid DNA from S1Vmac251(pBK28), was used as template in the PCR. One round of PCR amplification was used to amplify the missing proviral DNA using 30 cycles of 1.5 min at 94 °C, 2 min at 55 °C and 4 rain at 72 °C. The last cycle was completed with an extension time of 10 rain at 72 °C. The resulting PCR produced predominantly a single 1.2 kb fragment which was cloned into the EeoRI/BamHI site of pBluescript pSK--in Escherichia coli XLl-blue (Stratagene). Since pBK28 has a BamHI site within the nef gene, partial BamHI digestion was used in cloning the pBK28 PCR product. After sequencing of six clones from each PCR reaction, a clone from each was used to construct full-length proviral clones (Fig. 1) . The DNA insert from lambda clone 13-3 was ligated into the EcoRI site of the PCR clones and transformed into E. coli XLl-blue. All bacterial cultures were grown below 30 °C to prevent deletions in these large plasmid constructs (> 21 kb). Small-scale plasmid preparations of the resulting clones and BamHI digestion confirmed both the presence and orientation of the large DNA insert. large-scale plasmid preparation, sequencing and electroporation into human T cell lines: SIVmac32H(pJ5) from the JM cell construct, SIVmac32H(C8) from the C8166 cell construct and SIVmac32H(pB1) from the pBK28 construct. The origin of the SIVmac32H molecular clones in comparison with the other SIVmac molecular clones is summarized in Fig. 2 .
Nucleotide sequencing. The nucleotide sequence of the SIVmac32H clones was determined by subcloning appropriate restriction endonuclease fragments from the full-length molecular clones and nucleotide sequencing of both strands of DNA by primer-directed dideoxynucleotide chain termination (Sanger et al., 1977) using Sequenase (United States Biochemical) and internal primers synthesized in an ABI oligonucleotide synthesizer, a~S-labelled sequencing reactions were separated in 6 % polyacrylamide gels with 8 M-urea and sequences were analysed with both Microgenie (Amersham) and PCGene (Intelligenic) DNA and protein analysis software. The SIVmac32H sequence was compared with the sequences of SIVmac251, SIVmac239, SIVmac 1A 11 and SIVmac142 as they appear in the Human Retrovirus and AIDS database at the Los Alamos National Laboratory, U.S.A.
DNA transfections and growth characteristics of cloned virus. The three SIVmac32H molecular clones pJ5, pC8 and pB1 were electroporated into the C8166 cell line, SIVmac251 (pBK28) (positive control) and the incomplete genomic clone p 13-3 (negative control) were used as controls. Briefly, 10 p.g of plasmid DNA was added to 2-5 x 106 cells in 0-25 ml of ice-cold RPMI 1640 containing 20 % FCS and incubated for 10 min on ice in a cuvette before being shocked once at 250 mV, 960 gF in an electroporation apparatus (Gene Pulser, Bio-Rad). The cuvette was then returned to ice for 10 min and the cells were added to 5 ml of prewarmed RPMI 1640 (10% FCS) and incubated at 37 °C in a T25 flask. At day 1, 5 ml of RPMI 1640 containing 1 x 106 cells was added to each flask and after 3 days the cells were transferred to T75 flasks containing 40 ml of RPMI 1640. Reverse transcriptase (RT) activity was monitored every 2 to 3 days and at day 12 cell-free virus stocks were stored at -70 °C in 1 ml aliquots.
Growth curves of the electroporated cell-free virus stocks were determined by infecting 2 x 108 C8166 cells with 0.5 ml of the cell-free virus. Since SIVmac32H(pJ5) produced one-half the amount of virus of the other clones as determined by RT activity, the other cell-free supernatants were diluted to one-half of their day 12 concentrations. The cells were left in contact with the virus for 1 h at 37 °C, were washed three times in RPMI 1640, and then resuspended in 40 ml of RPMI 1640 containing 10% FCS, 2mM-L-glutamine, 100 units/ml penicillin and 100 gg/ml streptomycin. Samples (1 ml) were taken three times weekly for 17 days without the addition of growth media.
To make cell-free virus stocks for macaque infections 1 ml of day 12 electroporated SIVmac32H(pJ5) and SIVmac32H(pC8) cell-free virus was used to infect 1 x 107 C8166 cells in 10 ml of RPMI 1640 containing 10 % FCS and 2 mM-L-glutamine. On day 3, 40 ml of freshly split C8166 cells was added at 1 x l0 s cells/ml and on day 7 a further 200 ml of cells was added. On day 10, two-hundred 1 ml aliquots were made from the cell-free culture supernatants (9/90 cell-free virus pool) and these aliquots were titrated on C8166 cells (in vitro titre) and used for macaque infections. The remaining 50 ml of infected cells was split in a ratio of 1:4 every 3 to 4 days for a total of 12 weeks (26 passages) to observe any changes of the molecularly cloned virus upon in vitro passage in C8166 cells. Virus from the 9/90 pool was also passaged on rhesus macaque PBMCs to produce a stock of virus free of C8166 cell proteins (3/92 pool, also called J5M). The 3/92 pool was titrated on C8166 cells and also in vivo.
Reverse transcriptase assay. RT activity was monitored by centrifuging 1 ml of cell culture supernatant in a Beckman TL-100 centrifuge (10 min, 40000 r.p.m., 4 °C) and solubilizing the virus pellet in 25 p.l of 500 mM-KC1, 0-5 % Triton X-100, 5 mN-Tris-HCl pH 7-5, 1 mM-PMSF and 5 mM-2-mercaptoethanol. Ten gl of the solubilized virus was added to 90 gl of an RT assay mixture to make a final concentration of 50 mM-Tris HC1 pH 8, 10 mM-MgC12, 5 mM-DTT, 0.05% NP40, 0-2mg/ml BSA, 20gCi/ml [~H]dTTP, and 5gg/ml poly(rA). p(dT)12 is-The mixture was incubated at 37 °C for 30 min, boiled for 5 min and 50 gl was spotted onto DEAE discs (Whatman). The dried discs were washed in 2 x SSC, dried and the incorporated radioactivity was counted in scintillant.
Experimental i~fection of macaques. Chinese rhesus macaques, negative for SIV and simian D-type retrovirus antibodies, were infected with the 9/90 pool of cell-free virus derived from SIVmac32H(pJ5) and SIVmac32H9(pC8). Two macaques were inoculated intravenously with 1 ml of each cloned virus containing RT values of 5 x 105 c.p.m./ml. Macaques 45564 and 45569 were injected with SIVmac32H(pJ5) and macaques 45567 and 45568 were injected with SIVmac32H(pC8). Heparinized blood samples were collected every 2 weeks after inoculation for the first 10 weeks followed by once every 4 weeks and used for PBMC isolation, virus recovery and monitored for antibody response to SIV. Virus recovery from PBMCs was assessed by the presence of c.p.e., characterized by membrane ballooning and cell fusion, in C8166 cells co-cultivated with isolated PBMCs.
In order to determine an in vivo titre for vaccine studies, eight Indian rhesus macaques were inoculated intravenously with 2 ml of the 9/90 pool of SIVmac32H9(pJ5), at a range of dilutions between 10 -2 and 10 6. Similarly another eight Indian rhesus macaques were inoculated with dilutions of the 3/92 pool of rhesus macaque PBMC-grown SIVmac32H(pJ5). In order to determine infectivity in cynomolgus macaques, two animals were infected with a 10 -1 dilution of the 9/90 pool of SIVmac32H(pJ5) and four were infected with a 10 -1 dilution of the 9/90 pool of SIVmac32H(pC8). After the determination of the rhesus macaque in vivo titre, duplicate cynomolgus macaques were inoculated intravenously with either 100, 10 or 1 median animal infectious doses (AIDs0) of the 3/92 pool of SIVmac32H(pJ5) to determine whether these doses infected this species. All of the above macaques were followed for signs of AIDS-like disease. All animals were housed in accordance with the Home Office code of practice for the housing and care of animals used in scientific procedures (1989) . Animals were anaesthetized with ketamine hydrochloride for all procedures requiring removal from their cages.
nef PCR analysis of infected macaque PBMCs. DNA was isolated, using the same procedures as described above for cloning, from approximately 106 infected macaque PBMCs and the nef gene was amplified using nested-set PCR. Two rounds of amplification were used to obtain enough product for cloning. BamHI site). The DNA from approximately 105 PMBCs was added to the first round of PCR. The PCR reaction conditions were identical to those described above. One-tenth of the second round PCR products were digested with AflIII, which digests the nef gene from SIVmac32H(pJ5) only. The digested DNA was separated in a 1.5 % agarose gel and vacuum-blotted onto Hybond N + (Amersham). The products were identified as being nef-specific by hybridization with a nick-translated SIVmac32H(pJ5) nef gene clone. The PCR products were also BamHI-cut (sites within the PCR primers), cloned into pBluescript and sequenced, as described above.
Virion protein analysis. Crude virus pellets were prepared from virus passaged in vitro and virus reisolated from the PBMCs of infected macaques. The virus was pelleted (Beckman SW28, 25 000 r.p.m., 4 °C, 1 h) from 200 ml of cell-free culture supernatant and resuspended in 200 pl of Laemmli sample buffer. The denatured proteins were separated on 12.5 % polyacrylamide gels and blotted onto nitrocellulose membranes. After blocking of non-specific binding with 5 % skimmed milk (Marvel), the membranes were incubated with a 1 : 100 dilution of a SIVmac251 transmembrane glycoprotein-specific mouse monoclonal antibody, KK7 (Kent et al., 1991) , or SIVmac32H-positive macaque serum. 125I-labelled protein A was used to detect bound antibody. The washed and dried membranes were exposed to X-ray film.
Results

Sequence analysis of the SIVmac32H molecular clones
The complete proviral sequence of SIVmac32H has been determined from the molecular clone SIVmac32H(pJ5). It should be noted that SIVmac32H(pJ5) is the only SIVmac molecular clone to have no premature stop codons in any of its genes.
The three SIVmac32H molecular clones discussed in this paper, SIVmac32H(pJ5), SIVmac32H(pC8) and SIVmac32H(pB 1), differ from each other commencing at a naturally occurring EcoRI site located 9033 nucleotides from the 5' end of the 5' LTR. This divergent region, nucleotides 9033 to 10277, encodes the C terminus of rev and env, the full length of nef and the complete 3' LTR. The SIVmac32H(pJ5) nucleotide sequence, predicted translation products, and sequence motifs of this region are presented in Fig. 3 . Also presented are the nucleotide and corresponding amino acid sequence changes observed in SIVmac32H(pCS). The nucleotide changes in SIVmac32H(pC8) result only in amino acid changes in the nef protein and changes in the 3' LTR. nef mRNA from SIVmac251-infected cells (Colombini et al., 1989) encodes a nef protein with a three amino acid deletion (amino acids 148 to 150), one amino acid downstream of the SIVmac32H(pC8) deletion. The 12 bp deletion in SIVmac32H(pC8) results in a deletion of nucleotides -466 to -477 relative to the SIVmac32H (pJ5) 3' LTR U3 region (nucleotides 9501 to 9512). The SIVmac32H(pB1) clone contains the SIVmac251-(pBK28) nefgene which contains a deletion of nucleotide 9771 (T) relative to SIVmac32H(pJ5). This deletion changes the reading frame and consequently the nef protein from amino acid 233, resulting in a 247 instead of 263 amino acid protein.
Tissue culture infectivity
Each SIVmac32H molecular clone was electroporated into C8166 cells. Twelve days after electroporation the cell culture supernatant RT levels were approximately 2 × 106 c.p.m./ml for SIVmac251(pBK28), SIVmac32H (pC8) and SIVmac32H(pB1), and 1 × 10 G for SIVmac32H(pJ5) transfected cells. To examine their growth kinetics 5 x 10 ~ c.p.m, of each virus was used to infect C8166 cells. The growth curves for SIVmac32H (pJ5), SIVmac32H(pC8) and SIVmac32H(pB1) were essentially identical (Fig. 4) . Therefore the defect in the nefgene of SIVmac32H(pC8) or SIVmac32H(pB1) gives them no replicative advantage nor disadvantage for growth in C8166 cells. As SIVmac32H(pC8) and SIVmac32H(pJ5) differed essentially only by the four amino acid deletion in the nef protein it was decided to compare their in vivo infectivity. Virus from SIVmac32H (pB1) was not used because it had many more changes from the sequence of SIVmac32H(pJ5). Virus from the SIVmac32H molecular clones also grew well on MT4 and CEMX174 cells (data not shown); however, they did not grow appreciably on HUT78 cells (observed for 21 days).
Macaque infectivity
To determine whether there was any difference in in vivo virus infectivity, pairs of Chinese rhesus macaques were infected with either virus from SIVmac32H(pJ5) or SIVmac32H(pC8) (9/90 pools). The macaques were infected with an equivalent titre (approximately 105 TCIDs0/ml ) of virus. Blood samples were taken every 2 weeks until 10 weeks, then monthly. PBMCs were isolated and co-cultivated with freshly passaged C8166 cells. The time to appearance of c.p.e, was used as a crude measure of virus load. Most cultures were analysed for 30 to 35 days, although those sampled at weeks 8 and 10 were maintained for longer (Table 1) . Virus could be recovered from SIVmac32H(pCS)-infected macaques for the first 20 weeks post-infection (p.i.), but not reproducibly after that time, whereas virus was isolated from SIVmac32H(pJ5)-infected macaques for at least 40 weeks. In general, virus recovery by co-cultivation of PBMC with C8166 cells was slower than seen with PBMC taken from animals infected with uncloned virus (data not shown); this difference may have been due to the different origins of the macaques (Chinese rather than Indian). These macaques were killed 1 year after infection and postmortem examination reveaied no abnormalities. The only haematological abnormality observed was that the T4/T8 lymphocyte ratio in both SIVmac32H(pJ5)-infected macaques remained below 1 whereas that of the SIVmac(pCS)-infected macaques remained above 1 (L. A. E. Ashworth et al., personal communication). Virus was recovered from various tissues in both of the SIVmac32H(pJ5)-infected macaques and in one of the two SIVmac32H(pC8)-infected macaques. As it has been suggested that Chinese rhesus macaques may be more resistant to AIDS-related 9010  9020  9030  9040  9050  9060  9070  9080  9090  9100  9110  9120  I  1 1 EcoRI 9130  9140  9150  9160  9170  9180  9190  9200  9210  9220  9230  9240  I  I  I  I  I  I  I  i  I  I  I 9250  9260  9270  9280  9290  9300  9310  9320  9330  9340  9350  9360  I  [  I  i  I  i  I  1  I  I (pB1) is not shown as it was derived Rom SIVmac251(pBK28) and has been published elsewhere (Naidu et al., 1988) . The nucleotides in bold and underlined indicate divergent sequences [the change within SIVmac32H(pC8) shown below].
Where a nucleotide change results in an amino acid change, the appropriate amino acids are underlined and the change is shown below. The location of the 3' LTR and its sequence motiR are indicated. The deletion within SIVmac32H(pC8) results in the deletion of the ~ur underlined amino acids.
pathogenesis, the 9/90 pool of SIVmac32H(pJ5) was subsequently titrated in Indian rhesus macaques. The AIDs0 was found to be 10-6/2 ml. The AIDs0 data were determined by virus isolation (c. assay a n d one ( m a c a q u e 43M) h a d to be killed o w i n g to its m o r i b u n d c o n d i t i o n . This m a c a q u e b e g a n to lose weight a n d its T 4 / T 8 l y m p h o c y t e ratio b e g a n to d r o p at 10 m o n t h s p.i. P o s t m o r t e m e x a m i n a t i o n revealed that this a n i m a l h a d several p a t h o l o g i c a l a b n o r m a l i t i e s consistent with SIV infection i n c l u d i n g l y m p h n o d e hyperplasia, interstitial p n e u m o n i a a n d B cell lymp h o m a s localized to the eye a n d b l a d d e r (G. Hall et al., p e r s o n a l c o m m u n i c a t i o n ) . All infected m a c a q u e s showed signs of l y m p h a d e n o p a t h y early after infection, with the higher doses resulting in earlier a n d larger e n l a r g e m e n t (M, D e n n i s et al., u n p u b l i s h e d results), T h e S I V m a c 3 2 H PBMCs from infected rhesus macaques were harvested at 1 month (lanes 1 to 12)and 10 months (lanes 13 to 16)p.i. Nested PCR was used to amplify the nefgene from these samples and the resulting products were digested with AfllII and separated on a 1.5% agarose gel, vacuum-blotted onto Hybond N + (Amersham) and hybridized with a nick-translated SIVmac32H(pJ5) nefgene clone. Lanes 1 to 8 originate from the titration of the 9/90 pool of SIVmac32H(pJ5) in Indian rhesus macaques (lane 1, macaque 21M, 10-1; lane 2, macaque 31M, 10-6; lane 3, macaque 43M, 10-a; lane 4, macaque 57M, 10-5; lane 5, macaque L18, 10 6; lane 6, macaque L27, 10-4; lane 7, macaque L28, 10-5; lane 8, macaque L39, 10-4). Lanes 9 to 16 originate from the infection of two Chinese rhesus macaques, 45564 and 45569 (lanes 9, 13 and 12, 16, respectively) with virus from SIVmac32HlpJ5) and two Chinese rhesus macaques, 45567 and 45568 (lanes 10, 14 and 11, 15, respectively) with virus from SIVmac32H(pCS).
T a b l e 1. Reisolation o f S I V m a c 3 2 H f r o m infected Chinese rhesus macaques
(pJS) 9 / 9 0 p o o l further passaged o n m a c a q u e P B M C s [3/92 pool (J5M)] was f o u n d to have a n in vivo titre o f 10 4/2 ml a n d a similar in vitro titre was d e t e r m i n e d o n C8166 cells. C y n o m o l g u s m a c a q u e s were infected with virus derived f r o m S l V m a c 3 2 H ( p J 5 ) a n d S I V m a c 3 2 H ( p C S ) to d e t e r m i n e w h e t h e r these m o n k e y s are susceptible to these viruses and to verify that the in vivo titre, as determined with rhesus macaques, was valid in cynomolgus macaques. All of the cynomolgus macaques infected with the 9/90 pools of SIVmac32H(pJ5) and SIVmac32H(pC8) became infected as determined by virus isolation and PCR analysis (N. Almond, personal communication). Both macaques inoculated with 100 and 10 AIDs0 of the 3/92 pool of SIVmac32H(pJ5) became infected, whereas neither of the two inoculated with 1 AIDs0 became infected. One of the two macaques (K104) infected with the 9/90 pool of SIVmac32H(pJ5) showed signs of AIDS and was killed at 9 months p.i. This animal had lost 20% of its body weight, had chronic diarrhoea, a mild temperature and inguinal lymph node enlargement; haematologically it had lost more than half of its lymphocytes. Postmortem examination revealed pneumonic lesions, mesenteric lymph node enlargement and an enlarged large intestinal wall. SIV was isolated from blood, spleen and lymph nodes. The second macaque infected with the 9/90 pool of SIVmac32H(pJ5) had no AIDS-like illness when it was killed 1 year after infection. The other cynomolgus macaques had, at the time of submission of this paper, been infected for less than 9 months and had not shown AIDS-like signs of disease (E. J. Stott et al., personal communication) . As with the Chinese rhesus macaques, all of the cynomolgus macaques infected with the 9/90 pool of SIVmac32H(pC8) became intermittently positive for virus isolation after less than 6 months of infection and this was in contrast to the macaques infected with the 9/90 pool of SIVmac32H(pJ5) (Rud et al., 1994 ; N. Almond et aI., unpublished results).
PCR amplification and sequence analysis of nef genes circulating in infected PBMCs
The sequence of the nef gene circulating in macaques infected with either SIVmac32H(pJ5) or SIVmac32H (pC8) was determined after PCR amplification. The ability to PCR-amplify the nef gene paralleled the virus isolation data. The nef gene was PCR-amplified from PBMCs isolated from both SIVmac32H(pJ5)-infected macaques at 4 and 40 weeks after infection, but only from one of the SIVmac32H(pC8)-infected macaques ( Fig. 5, lanes 9 to 16) . The deletion in the nef gene of SIVmac32H(pC8) removes a unique AflIII site in the SIVmac32H(pJ5) nef gene. The lack of this AflIII site from the nef gene circulating in the SIVmac32H(pC8)-infected macaque indicated that this deletion was retained until at least 40 weeks p.i. Sequence analysis of the PCR-amplified nef genes from these macaques confirmed the maintenance of this deletion. One month p.i. all the provirus circulating in the SIVmac32H(pJ5)-infected macaque and 50 % of the provirus circulating in the SIVmac32H(pC8)-infected macaque had nucleotide changes from the input sequences. At 10 months p.i. however, the nefgene sequence in the SIVmac32H(pC8)-infected macaque remained unchanged from the input clone sequence, whereas all of the nef gene sequences in the SIVmac32H(pJ5)-infected macaque had nucleotide changes resulting in amino acid changes. Each clone from the SIVmac32H(pJ5)-infected macaque at 10 months p.i. was unique in sequence. A summary of the nef amino acid changes and frequency of these changes in both the SIVmac32H(pJ5)-and SIVmac32H(pCS)-infected Chinese rhesus macaques are shown in Fig. 6 . It is of interest that at 1 month p.i., a single clone (11-8) from the SIVmac32H(pC8)-infected macaque had an additional deletion of 62 bp around the original deletion, commencing at the first nucleotide of the 3' LTR, corresponding to nucleotides 9460 to 9533 from SIVmac32H(pJ5). This deletion resulted in a frameshift and premature termination of the nef protein. However, at 10 months p.i. this sequence was not observed. A similar additional deletion in the nef gene region overlapping with the LTR has been observed in macaques infected with SIVmac239 containing a large deletion in the nef gene between the end of the env gene and the start of the 3' LTR (R. C. Desrosiers et al., personal communication) . The extra deletion in this case was maintained late in infection.
SIVmac32H virion proteins
To determine the effect of the deletion within nef in SIVmac32H(pC8) on the adaptation of SIVmac32H to growth in human T cells the protein profiles of the uncloned and molecularly cloned viruses were compared by Western blot analysis of crude virus pellets prepared from cell-adapted virus or from PBMC cultures harvested at 4 or 6 weeks after infection. SIV-specific proteins were detected using SIV-positive macaque serum or a monoclonal antibody to the transmembrane protein (Fig. 7) . The SIV-positive serum shows a typical pattern of reactivity (Fig. 7 a) to the gag (p55, p28, p17), pol (p68, p59) and env (gpl60, gp125, gp42, gp37, gp32) proteins. The transmembrane protein varies in size (gp42, gp37, gp32) according to whether the virus has been passaged on human cells. Whereas the uncloned 11/88 pool of SIVmac32H, passaged repeatedly on human cells, contained a mixture of full-length and truncated transmembrane proteins (Fig. 7b, lanes 1 to 3) , the virus from SIVmac32H(pJ5) and SlVmac32H(pCS) (9/90 pools) contained only full-length transmembrane proteins (Fig. 7b, lanes 5 and 6) . The virus recovered from SIVmac32H(pJ5)-and SIVmac32H(pCS)-infected macaque PBMCs contained only full-length transmembrane proteins (Fig. 7b, lanes 11 to 14) . However, when the 9/90 pools of SIVmac32H(pJ5) and SIVmac32H(pC8) were subjected to prolonged passage on C8166 cells they both evolved into virus pools containing truncated transmembrane proteins (Fig. 7 b , lanes 7 to 10). Therefore, the deletion in the nefgene in SIVmac32H(pC8) did not affect its premature termination adaptation to growth in human T cells. Interestingly, two forms of truncated transmembrane proteins were observed (37K and 32K) and upon long-term passage only the lower M~. form persisted (Fig. 7b , lanes 1 to 3). It is of interest that the extracellular virus produced by the JM cells used to isolate the molecular clones predominantly contained a 32K transmembrane protein (Fig. 7b, lane 4) , whereas the molecular clones contained a full-length transmembrane protein (Fig. 7 b , lanes 5 and 6). Therefore, either the integrated provirus within JM cells does not represent the virus produced from these cells and unintegrated provirus produces most of the virus, or the clones represent a very rare member of the integrated provirus. The second possibility is not supported by sequence analysis of gp41 gag PCR products from JM cells (results not shown), where no premature termination codons were detected.
Discussion
In this paper we report that SIVmac32H molecular clones differing within their nef genes do not differ in their replication in T cell lines. This report is similar to the reports of Kim et al. (1989) , Hammes et al. (1989) and De Ronde et al. (1992) for HIV-1 and Kestler et al. (1991) for SIVmac239, but differs from that of Binninger et al. (1991) , who found that SIVmac251 nef mutants (generated in vitro) have faster growth kinetics when infected into tissue culture at very low m.o.i. Our results were obtained with a higher m.o.i, of 0"5 and Binninger et al. (1991) report that at high m.o.i, they could not observe any difference in growth kinetics between their mutants. De Ronde et al. (1992) compared the growth patterns of nef+ and nef-HIV-1 in Jurkat T cells and primary human PBMCs and found no difference in Jurkat cells, whereas the nef+ virus grew significantly better when grown in PBMCs. These results agree with those of Kestler et al. (1991) for SIVmac239 in macaques, who found that virus with an in vitro generated deletion in the nef gene could infect rhesus macaques but produced only a low virus yield. Our results agree with those of Kestler et al. (1991) in that virus can be recovered from PBMCs for a shorter time from the macaques infected with the nef gene containing a naturally generated deletion. It should be stressed that the deletion in SIVmac32H(pCS) is an in-frame deletion of only 12 nucleotides and produces a nef protein four amino acids shorter than that of SIVmac32H(pJ5), unlike the large, out-of-frame deletions created in other studies with SIV nef (Kestler et al., 1991; Unger et al., 1992) . Further indication that the internal nef deletion has affected the virus yield comes from sequence analysis of the PCR-generated nef gene products. The provirus circulating in the macaques infected with virus containing the full-length nef gene showed amino acid sequence variation over 10 months of infection, whereas that of the macaque infected with virus containing the internally deleted nef gene remained invariant in sequence at 10 months p.i. This is presumably a consequence of the lower virus yield in macaques infected with nef deletion virus at a later time in infection. Early in infection, however, both the virus containing a nef deletion and a full-length nef gene have similar degrees of evolution. One interpretation of these results could be that macaques infected with nef deletion virus are able to mount an immune response that destroys most of the cells actively producing virus. The surviving infected cells would be only those containing latent provirus, hence the nucleotide sequence conservation. The consequence of deleting part of the nef gene of SIVmac is apparently to attenuate the virus and this observation has instigated the use of such viruses as live attenuated vaccines (Daniel et al., 1992; Rud et al., 1992) . The clones generated in this work will also be very useful for assessing the function of the nefprotein both in vitro and in vivo. The relative distribution of nefdeletion and fulllength nefviruses in infected macaques is being examined with these clones. It is of interest that the four amino acid deletion (amino acids 143 to 146) in SIVmac32H(pCS) is located between the three known SlVmac251 nef cytotoxic T lymphocyte (CTL) epitopes (amino acids 108 to 125, 155 to 169 and 164 to 178) recognized by SIVmac251-infected macaque CTLs (Bourgault et al., 1992) . Whether this deletion has destroyed the processing site for the presentation of these CTL epitopic peptides on the surface of infected cells is under investigation. If these epitopes are not presented, this may be an example of the adaptation of SIVmac32H to avoid CTL-mediated immunological pressure. Recently, nef has also been reported to down-regulate surface expression of CD4 (Garcia & Miller, 1991) and to block the induction of IL-2 by mitogenic stimuli (Luria et al., 199t) . It wilt be of interest to examine the ability of the SIVmac32H molecular clones to modulate these activities. The deletion in the nefgene in SIVmac32H(pC8) also overlaps with the 5' end of the U3 region of the 3' LTR (Fig. 3) . The function of this region of the LTR is not defined; although it is close to the presumed negative regulatory element region, it cannot be ruled out that it may also have an influence on the in vivo growth characteristics of this virus. There are other changes in the 3' LTR of SIVmac32H(pC8) which may also play some role in the differences seen between macaques infected with virus derived from SIVmac32H(pJ5) and SIVmac32H(pC8). As shown in Fig. 3 these changes are not in any of the major transcriptional control elements (Spl and NF~-B binding sites, TATA box, polyadenylation signal). There is one change in the TAR element; however, it is at the extreme 3' end of the TAR motif and hence probably not important for TAR function (Cullen, 1991; Green, 1990) .
The 11/88 pool of SIVmac32H has been used as an uncloned SIVmac standard challenge virus Kitchin et al., 1990) . The gag and env sequence variants in this uncloned pool have been examined by Almond et al. (1992) . Comparison of the env gene sequence of SIVmac32H(pJ5) to those of the variants in the 11/88 pool shows that the V1/V2 region is essentially identical to the consensus sequence (Almond et al., 1992) and identical to five of the six sequences derived from a macaque infected with the 11/88 pool (E. G. J. Hulskotte et al., personal communication) and quite different in this region from the other SIVmac clones (SIVmac251, SIVmac239, SIVmaclAll and SIVmac142). It therefore appears that the SIVmac32H(pJ5) molecular clone represents a dominant virus within the 11/88 pool. The V3 region is identical to the consensus sequence and this region does not seem to be variable within SIV (Almond et al., 1992; Burns & Desrosiers, 1991) . The V4 region is identical to that of SIVmac251 but surprisingly differs significantly from the 11/88 consensus. This variation may have occurred when the 11/88 pool was passaged a further eight times on JM cells to obtain the proviral DNA used to clone SIVmac32H(pJ5). It is of interest that there is very little variation within the 11/88 pool in this region. Recently, Mori et al. (1992) reported that macrophage tropism for SIVmac239 was determined by the env gene. Within the env protein four amino acid changes (67 Val to Met, 176 Lys to Glu, 382 Gly to Arg and 751 Arg to Gly) universally correlated with macrophage tropism. The last two changes appear in the env protein of SIVmac32H (p J5). It will be of interest to determine whether virus from SIVmac32H(pJ5) will replicate in macrophages.
The 9/90 and 3/92(J5M) pools of SIVmac32H(pJ5) are being used in the U.K. as molecularly cloned vaccinechallenge viruses. The rhesus macaques infected with dilutions of the 9/90 pool have now been observed for 16 months. Only one animal has developed AIDS in this group and interestingly this was associated with B cell lymphomas. A similar association has been seen in animals infected with uncloned SIVmac32H. It will be interesting to determine whether these lymphomas are also associated with Epstein-Barr virus or an Epstei~ Barr-like virus as has been reported in another study of SIV-infected macaques (Feichtinger et al., 1992) . One of two cynomolgus macaques infected with the 9/90 pool of SIVmac32H(pJ5) developed an AIDS-like disease within 1 year of infection. The observation of AIDS-like disease and the initial lymphadenopathy in the infected macaques indicate that SIVmac32H(pJ5) is pathogenic in Indian rhesus and cynomolgus macaques. However, acute disease (death within 1 year) was only seen in fewer than 15 % of rhesus macaques, compared to 50 % of the macaques infected with SIVmac239. It should be noted however that a proportion of macaques infected with SIVmac239 have survived for up to 3 years p.i., indicating that there must be genetic variability in susceptibility to SIVmac239-induced AIDS-like disease. The remaining rhesus and cynomolgus macaques infected with SIVmac32H(pJ5), including those more recently infected with rhesus macaque PBMC-grown virus (3/92), are being followed for signs of AIDS-like disease. None of the macaques infected with virus from SIVmac32H(pCS) have shown signs of disease within a year of infection. In cynomolgus macaques infected with virus derived from SIVmac32H(pC8), the length of viraemia is at least a month shorter than in rhesus macaques (Rud et al., 1994; N. Almond et al., unpublished results) . However in both species the level of early cell-associated viraemia is similar, in terms of days to development of c.p.e, when PBMCs are co-cultivated with C8166 cells. This observation suggests that cynomolgus macaques may be able to clear PBMCs actively producing virus more efficiently than rhesus macaques. It should be stressed that in both species virus is still detectable by PCR late in infection (E. W. Rud & N. Almond, unpublished observations).
In a recent study (Daniel et al., 1992) , macaques resisted challenge with 1000 AIDso of pathogenic, wildtype SIVmac239 and SIVmac251, when they had been infected with the large nefdeletion version of SIVmac239 for more than 2 years prior to challenge. In parallel, SIVmac32H(pC8) is being examined as a potential attenuated vaccine in view of its apparent attenuated characteristics. Macaques infected with this virus will be challenged with SIVmac32H(pJ5) to determine whether superinfection can be prevented. The attenuated virus approach to AIDS vaccines has the inherent risk of reversion to virulence, consequently the development of Characterization of SIVmac32H proviral clones 541 multiple-deletion viruses would minimize this risk. There must be a point, however, where the extent of attenuation may prevent the full induction of protection seen with the nef deletion viruses.
In summary, two 32H molecular clones, SIVmac32H (p J5) and SIVmac32H(pCS), differ significantly from each other only by an in-frame deletion in the nefgene. This deletion results in a four amino acid loss from the centre of the nef protein. The other open reading frames within these clones do not contain premature termination codons. Macaques infected with the nef deletion virus maintain PBMC-associated viraemia for a shorter period than macaques infected with a fulMength nef virus. The provirus circulating in the macaque infected with the nef deletion virus has a restricted sequence evolution over time, to the extent that at 40 weeks p.i. no variation was observed, in comparison to the continually evolving provirus circulating in the macaque infected with the full-length nefvirus. Therefore, these molecularly cloned and characterized viruses have been chosen to examine the ability of subunit and attenuated versions of the clones to stimulate protective responses in vaccinated macaques. The 32H molecular clones are unique reagents with which to study the molecular basis of SIV-mediated pathogenesis and vaccine-induced protection.
